ArticleFrontiers in pharmacology2021
Accessibility of Medicines for Children: A Systematic Review.
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Poor-tasting pediatric medicines: Part 1. A scoping review of their impact on patient acceptability, medication adherence, and treatment outcomes.Frontiers in drug delivery · 2025Pooled it
- Global, regional and national availability of essential medicines for children, 2009-2020: a systematic review and meta-analysis.BMC public health · 2023Pooled it
- Access to child-appropriate medicines in community pharmacies in Albania: a cross-sectional survey using SDG indicator 3.b.3.BMJ open · 2026Article
- Parental preferences for generic substitution policies for children in China: a discrete choice experiment.BMJ open · 2026Article
- Technological and industrial trends in China's pharmaceutical sector.Frontiers in pharmacology · 2025Review
- Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil.Health research policy and systems · 2024Article
- Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines.Children (Basel, Switzerland) · 2024Article
- Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children.Journal of pharmaceutical policy and practice · 2024Article
- SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children.BMC health services research · 2023Article
- Article
- Medical treatment in infants and young children with epilepsy: Off-label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children.Epilepsia open · 2023Article
- Article
- Access to medicines for children in China.BMJ paediatrics open · 2022Review
- Missing data on accessibility of children's medicines.Bulletin of the World Health Organization · 2022Article
- Strengthen health systems to achieve the SDG targets for healthy children: Evidence on access to medicines situation in Nepal.The Lancet regional health. Southeast Asia · 2022Article
- Systems Challenges in Accessing Medicines among Children under Thailand's Universal Health Coverage: A Qualitative Study of a Provincial Public Hospital Network.Children (Basel, Switzerland) · 2022Article
- Accessibility of Essential Medicines for Children in Sichuan Province of China: A Cross-Sectional Study.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.